Carisma Therapeutics Inc - Multiplikator EV/Sales CARM

Carisma Tx (CARM) - logo korporat

Carisma Therapeutics (CARM) management is focusing on CAR-M platform trials, which supports the asset balance. The enterprise value-to-revenue multiple reflects the results of implementing macrophage therapy to combat solid tumors. Patent protection and strict FDA oversight create significant barriers to entry. The current determines the metric's magnitude by combining the market price with the company's operational efficiency.

Carisma Therapeutics Inc - Multiplikator EV/Sales CARM (periode 04.07.2022 - 20.11.2026)

CARM (Carisma Therapeutics Inc.): rincian analitis lan laporan miturut indikator

- nilai pasar lan prakiraan target analis:
Pambiji fundamental perusahaan:CARM - Carisma Therapeutics
Produk asli carismatx.com

The intensive development of CAR-macrophages to combat solid tumors makes Carisma Therapeutics (CARM) dependent on the valuation of future R&D successes. The EV/Sales multiple compares the total enterprise value, adjusted for net debt, against current sales, allowing investors to assess the extent to which the asset is overpriced relative to its operating revenue and the risks of a correction should the innovation cycle slow down.

Pesaing langsung

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Multiplikator EV/Sales CABA (cabalettabio.com)|Koefisien nilai perusahaan marang pendapatan VTYX (Ventyx Bio)|Theratechnologies, Inc - Multiplikator EV/Sales|AVTX (Avalo Therapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|eledon.com (ELDN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AGEN|CLYM (climbbio.com) - Multiplikator EV/Sales|Multiplikator EV/Sales zurabio.com|Rasio nilai perusahaan marang pendapatan aTyr (ATYR)|ADAG - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ImageneBio Inc IMA|Multiplikator EV/Sales Shattuck Labs, Inc. STTK|EQ - Rasio nilai perusahaan marang pendapatan|connectbiopharm.com (CNTB) - Nilai perusahaan marang pendapatan|IMUX (Immunic) - Nilai perusahaan marang pendapatan|Atara Biotherapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan InflaRx|Nilai perusahaan marang pendapatan x4pharma.com (XFOR)|Multiplikator EV/Sales ACET|Nilai perusahaan marang pendapatan Celularity Corp CELU|INmune Bio Inc - Nilai perusahaan marang pendapatan|BRNS (Barinthus Bio) - Nilai perusahaan marang volume dodolan|KZR - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Rasio nilai perusahaan marang pendapatan|ENLV - Rasio total nilai perusahaan marang pendapatan|QTTB (Q32 Bio) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan GeoVax Labs Inc GOVX|Rasio nilai perusahaan marang pendapatan Edesa Biotech (EDSA)|Nilai perusahaan marang pendapatan iBio IBIO|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD